\begin{table}[htbp]\centering
\def\sym#1{\ifmmode^{#1}\else\(^{#1}\)\fi}
\caption{Summary statistics for selected variables}
\begin{tabular}{l*{1}{cccc}}
\hline\hline
                    &        Mean&     Minimum&     Maximum&Observations\\
\hline
Uses biomarker      &      0.4074&           0&           1&      13,197\\
Generous PPM        &      0.0631&           0&           1&      13,197\\
Restrictive PPM     &      0.0558&           0&           1&      13,197\\
Biomarker role: disease&      0.0819&           0&           1&      13,197\\
Biomarker role: toxic effect&      0.0508&           0&           1&      13,197\\
Biomarker role: therapeutic effect&      0.3392&           0&           1&      13,197\\
Biomarker role: not determined&      0.0025&           0&           1&      13,197\\
Biomarker type: anthropomorphic&      0.0349&           0&           1&      13,197\\
Biomarker type: biochemical&      0.1277&           0&           1&      13,197\\
Biomarker type: cellular&      0.0310&           0&           1&      13,197\\
Biomarker type: genomic&      0.2316&           0&           1&      13,197\\
Biomarker type: physiological&      0.0840&           0&           1&      13,197\\
Biomarker type: proteomic&      0.2414&           0&           1&      13,197\\
Biomarker type: structural (imaging)&      0.0175&           0&           1&      13,197\\
Biomarker role (detailed): diagnosis&      0.2980&           0&           1&      11,750\\
Biomarker role (detailed): differential diagnosis&      0.1823&           0&           1&      11,750\\
Biomarker role (detailed): predicting drug resistance&      0.0618&           0&           1&      11,750\\
Biomarker role (detailed): predicting treatment efficacy&      0.2580&           0&           1&      11,750\\
Biomarker role (detailed): predicting treatment toxicity&      0.0491&           0&           1&      11,750\\
Biomarker role (detailed): screening&      0.0541&           0&           1&      11,750\\
Biomarker role (detailed): selection for therapy&      0.0942&           0&           1&      11,750\\
Phase 1 Clinical    &      0.3387&           0&           1&      13,197\\
Phase 2 Clinical    &      0.4339&           0&           1&      13,197\\
Phase 3 Clinical    &      0.2274&           0&           1&      13,197\\
Received NIH funding&      0.0260&           0&           1&      13,197\\
Trial site in US    &      0.4402&           0&           1&      11,331\\
Drug indication for neoplasm&      0.3336&           0&           1&      13,197\\
\hline
N                   &      13,197&            &            &            \\
\hline\hline
\end{tabular}
\end{table}
